We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Fetal Monitors Offer Safety Features

By HospiMedica staff writers
Posted on 28 Feb 2006
A new line of fetal and maternal monitors for obstetrical care offer advanced functionality and safety features. More...


The new Avalon fetal monitors, manufactured by Philips Medical Systems (Andover, MA, USA), feature enhanced functionality and documentation capabilities and are compact and ergonomic as well. The Avalon FM20 (antepartum) and Avalon FM30 (intrapartum) monitors can be used to monitor multiple births, with advanced features that include high-quality ultrasound tracing and cross-channel verification, a Philips safety feature that reduces the risk of confusing maternal and fetal heart rate signals.

Both monitors integrate monitoring of maternal blood pressure and pulse rate with measurement of multiple fetal heart rates and uterine activity. Data from the monitors can be automatically transmitted to the Philips OB TraceVue obstetrical information system for comprehensive information management across the obstetrical care continuum, from the beginning of pregnancy to postpartum visits across multiple pregnancies.

The Avalon FM20 offers fetal and maternal monitoring for obstetrical departments in offices, clinics, and hospitals. It integrates monitoring of maternal blood pressure and pulse rate with measurement of multiple fetal heart rates and uterine activity.

The Avalon FM30 covers patients from the onset of contractions through the final stages of delivery with its full set of external and internal fetal parameters, such as fetal heart rate via ultrasound or direct fetal electrocardiogram (ECG), intrauterine pressure, and internal and external uterine activity. It provides non-invasive monitoring of maternal blood pressure, maternal pulse oximetry, heart rate, and maternal electrocardiogram (ECG) wave.

"Obstetrics commands the highest standards in patient safety and documentation,” said David Russell, vice president of global marketing, patient monitoring, for Philips Medical Systems. "Our new fetal monitors are designed to help clinicians improve patient outcomes with reliable monitoring throughout a mother's pregnancy.



Related Links:
Philips Medical Systems

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Blood Bank Refrigerator
MBR-705GR-PE
Cardiograph Device
PageWriter TC35
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.